SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001753926-20-000332
Filing Date
2020-10-09
Accepted
2020-10-08 20:01:27
Documents
3
Group Members
ELIYAHU HASSETT

Document Format Files

Seq Description Document Type Size
1 SC 13D g082042_sc13d.htm SC 13D 104114
2 EXHIBIT 99.1 g082042_ex99-1.htm EX-99.1 30209
3 EXHIBIT 99.2 g082042_ex99-2.htm EX-99.2 8936
  Complete submission text file 0001753926-20-000332.txt   145130
Mailing Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Subject) CIK: 0001424812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87050 | Film No.: 201231889
SIC: 2834 Pharmaceutical Preparations

Mailing Address PALM GROVE HOUSE, P.O. BOX 438 ROAD TOWN, TORTOLLA D8 VG1110
Business Address PALM GROVE HOUSE, P.O. BOX 438 ROAD TOWN, TORTOLLA D8 VG1110 3 505-600-4050
Lorient Ventures Ltd (Filed by) CIK: 0001827787 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D